Anemia drepanocitica (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Anemia drepanocitica" in Italian language version.

refsWebsite

Global rank Italian rank

23nih.gov

4^th place

9^th place

16doi.org

2^nd place

7^th place

13oadoi.org

799^th place

22^nd place

1who.int

195^th place

342^nd place

1google.ca

838^th place

542^nd place

1ecu.edu

low place

1worldcat.org

5^th place

26^th place

1unibo.it

4,963^rd place

325^th place

doi.org

dx.doi.org

(EN) Collaborators Global Burden of Disease Study 2013, Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013., in Lancet, vol. 386, n. 9995, 22 agosto 2015, pp. 743-800, DOI:10.1016/s0140-6736(15)60692-4, PMID 26063472.
(EN) DC Rees, TN Williams e MT Gladwin, Sickle-cell disease, in Lancet, vol. 376, n. 9757, 11 dicembre 2010, pp. 2018-31, DOI:10.1016/s0140-6736(10)61029-x, PMID 21131035.
Collaborators GBD 2013 Mortality and Causes of Death, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013., in Lancet, vol. 385, 17 dicembre 2014, pp. 117-171, DOI:10.1016/S0140-6736(14)61682-2, PMC 4340604, PMID 25530442.
(EN) Todd L. Savitt e Morton F. Goldberg, Herrick's 1910 case report of sickle cell anemia. The rest of the story (PDF), in JAMA, vol. 261, n. 2, 13 gennaio 1989, pp. 266-71, DOI:10.1001/jama.261.2.266, PMID 2642320.
(EN) Graham R. Serjeant, One hundred years of sickle cell disease, in British Journal of Haematology, vol. 151, n. 5, dicembre 2010, pp. 425-9, DOI:10.1111/j.1365-2141.2010.08419.x, PMID 20955412.
(EN) Irene Roberts e Mariane de Montalembert, Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe, in Haematologica, vol. 92, n. 7, luglio 2007, pp. 865-71, DOI:10.3324/haematol.11474, PMID 17606434.
(EN) Thomas E. Wellems, Karen Hayton e Rick M. Fairhurst, The impact of malaria parasitism: from corpuscles to communities, in The Journal of Clinical Investigation, vol. 119, n. 9, 1º settembre 2009, pp. 2496-505, DOI:10.1172/JCI38307, PMC 2735907, PMID 19729847.
(EN) Oniyangi O, Omari AA, Malaria chemoprophylaxis in sickle cell disease, in Oluseyi Oniyangi (a cura di), Cochrane Database of Systematic Reviews, vol. 13, n. 4, 2006, pp. CD003489, DOI:10.1002/14651858.CD003489.pub2, PMID 17054173.
(EN) Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia, in The New England Journal of Medicine, vol. 332, n. 20, 18 maggio 1995, pp. 1317-22, DOI:10.1056/NEJM199505183322001, ISSN 0028-4793 (WC · ACNP), PMID 7715639.
(EN) Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M, Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment, in JAMA, vol. 289, n. 13, 2 aprile 2003, pp. 1645-51, DOI:10.1001/jama.289.13.1645, PMID 12672732.
(EN) Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J, Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members., in JAMA, vol. 312, n. 10, 10 settembre 2014, pp. 1033-48, DOI:10.1001/jama.2014.10517, PMID 25203083.
(EN) Orah S. Platt, Hydroxyurea for the treatment of sickle cell anemia, in The New England Journal of Medicine, vol. 358, n. 13, 27 marzo 2008, pp. 1362-9, DOI:10.1056/NEJMct0708272, PMID 18367739.
(EN) Drasar E, Igbineweka N, Vasavda N, Free M, Awogbade M, Allman M, Mijovic A, Thein SL, Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years, in British Journal of Haematology, vol. 152, n. 6, marzo 2011, pp. 766-70, DOI:10.1111/j.1365-2141.2010.08451.x, PMID 21275951.
(EN) Gyang E, Yeom K, Hoppe C, Partap S, Jeng M, Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease, in American Journal of Hematology, vol. 86, n. 1, gennaio 2011, pp. 104-6, DOI:10.1002/ajh.21901, PMID 21117059.
(EN) Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, Dumont MD, Lenoir G, de Montalembert M, Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease, in European Journal of Haematology, vol. 84, n. 3, marzo 2010, pp. 259-65, DOI:10.1111/j.1600-0609.2009.01379.x, PMID 19912310.
(EN) Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, Davies SC, Ohene-Frempong K, Bernaudin F, Matthews DC, Storb R, Sullivan KM, Bone marrow transplantation for sickle cell disease, in The New England Journal of Medicine, vol. 335, n. 6, 8 agosto 1996, pp. 369-76, DOI:10.1056/NEJM199608083350601, PMID 8663884.

ecu.edu

(EN) Todd L. Savitt e Morton F. Goldberg, Herrick's 1910 case report of sickle cell anemia. The rest of the story (PDF), in JAMA, vol. 261, n. 2, 13 gennaio 1989, pp. 266-71, DOI:10.1001/jama.261.2.266, PMID 2642320.

google.ca

books.google.ca

(EN) Abdelaziz Y. Elzouki, Textbook of Clinical Pediatrics, 2ª ed., Berlino, Springer, 2012, p. 2950, ISBN 978-3-642-02201-2.

nih.gov

ncbi.nlm.nih.gov

(EN) Collaborators Global Burden of Disease Study 2013, Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013., in Lancet, vol. 386, n. 9995, 22 agosto 2015, pp. 743-800, DOI:10.1016/s0140-6736(15)60692-4, PMID 26063472.
(EN) DC Rees, TN Williams e MT Gladwin, Sickle-cell disease, in Lancet, vol. 376, n. 9757, 11 dicembre 2010, pp. 2018-31, DOI:10.1016/s0140-6736(10)61029-x, PMID 21131035.
Collaborators GBD 2013 Mortality and Causes of Death, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013., in Lancet, vol. 385, 17 dicembre 2014, pp. 117-171, DOI:10.1016/S0140-6736(14)61682-2, PMC 4340604, PMID 25530442.
(EN) Todd L. Savitt e Morton F. Goldberg, Herrick's 1910 case report of sickle cell anemia. The rest of the story (PDF), in JAMA, vol. 261, n. 2, 13 gennaio 1989, pp. 266-71, DOI:10.1001/jama.261.2.266, PMID 2642320.
(EN) Graham R. Serjeant, One hundred years of sickle cell disease, in British Journal of Haematology, vol. 151, n. 5, dicembre 2010, pp. 425-9, DOI:10.1111/j.1365-2141.2010.08419.x, PMID 20955412.
(EN) Weatherall DJ, Clegg JB, Inherited haemoglobin disorders: an increasing global health problem (PDF), in Bulletin of the World Health Organization, vol. 79, n. 8, 2001, pp. 704-12, PMC 2566499, PMID 11545326.
(EN) Irene Roberts e Mariane de Montalembert, Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe, in Haematologica, vol. 92, n. 7, luglio 2007, pp. 865-71, DOI:10.3324/haematol.11474, PMID 17606434.
(EN) Thomas E. Wellems, Karen Hayton e Rick M. Fairhurst, The impact of malaria parasitism: from corpuscles to communities, in The Journal of Clinical Investigation, vol. 119, n. 9, 1º settembre 2009, pp. 2496-505, DOI:10.1172/JCI38307, PMC 2735907, PMID 19729847.
(EN) Oniyangi O, Omari AA, Malaria chemoprophylaxis in sickle cell disease, in Oluseyi Oniyangi (a cura di), Cochrane Database of Systematic Reviews, vol. 13, n. 4, 2006, pp. CD003489, DOI:10.1002/14651858.CD003489.pub2, PMID 17054173.
(EN) Jeffrey Glassberg, Evidence-based management of sickle cell disease in the emergency department., in Emergency Medicine Practice, vol. 13, n. 8, agosto 2011, pp. 1–20; quiz 20, PMID 22164362.
(EN) Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia, in The New England Journal of Medicine, vol. 332, n. 20, 18 maggio 1995, pp. 1317-22, DOI:10.1056/NEJM199505183322001, ISSN 0028-4793 (WC · ACNP), PMID 7715639.
(EN) Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M, Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment, in JAMA, vol. 289, n. 13, 2 aprile 2003, pp. 1645-51, DOI:10.1001/jama.289.13.1645, PMID 12672732.
(EN) Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J, Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members., in JAMA, vol. 312, n. 10, 10 settembre 2014, pp. 1033-48, DOI:10.1001/jama.2014.10517, PMID 25203083.
(EN) Orah S. Platt, Hydroxyurea for the treatment of sickle cell anemia, in The New England Journal of Medicine, vol. 358, n. 13, 27 marzo 2008, pp. 1362-9, DOI:10.1056/NEJMct0708272, PMID 18367739.
(EN) Drasar E, Igbineweka N, Vasavda N, Free M, Awogbade M, Allman M, Mijovic A, Thein SL, Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years, in British Journal of Haematology, vol. 152, n. 6, marzo 2011, pp. 766-70, DOI:10.1111/j.1365-2141.2010.08451.x, PMID 21275951.
(EN) Gyang E, Yeom K, Hoppe C, Partap S, Jeng M, Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease, in American Journal of Hematology, vol. 86, n. 1, gennaio 2011, pp. 104-6, DOI:10.1002/ajh.21901, PMID 21117059.
(EN) Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, Dumont MD, Lenoir G, de Montalembert M, Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease, in European Journal of Haematology, vol. 84, n. 3, marzo 2010, pp. 259-65, DOI:10.1111/j.1600-0609.2009.01379.x, PMID 19912310.
(EN) Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, Davies SC, Ohene-Frempong K, Bernaudin F, Matthews DC, Storb R, Sullivan KM, Bone marrow transplantation for sickle cell disease, in The New England Journal of Medicine, vol. 335, n. 6, 8 agosto 1996, pp. 369-76, DOI:10.1056/NEJM199608083350601, PMID 8663884.

nhlbi.nih.gov

(EN) What Is Sickle Cell Disease?, su National Heart, Lung, and Blood Institute, 12 giugno 2015. URL consultato l'8 marzo 2016.
(EN) What Are the Signs and Symptoms of Sickle Cell Disease?, su National Heart, Lung, and Blood Institute, 12 giugno 2015. URL consultato l'8 marzo 2016.
(EN) What Causes Sickle Cell Disease?, su National Heart, Lung, and Blood Institute, 12 giugno 2015. URL consultato l'8 marzo 2016.
(EN) How Is Sickle Cell Disease Diagnosed?, su National Heart, Lung, and Blood Institute, 12 giugno 2015. URL consultato l'8 marzo 2016.
(EN) How Is Sickle Cell Disease Treated?, su National Heart, Lung, and Blood Institute, 12 giugno 2015. URL consultato l'8 marzo 2016.

oadoi.org

(EN) Collaborators Global Burden of Disease Study 2013, Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013., in Lancet, vol. 386, n. 9995, 22 agosto 2015, pp. 743-800, DOI:10.1016/s0140-6736(15)60692-4, PMID 26063472.
(EN) DC Rees, TN Williams e MT Gladwin, Sickle-cell disease, in Lancet, vol. 376, n. 9757, 11 dicembre 2010, pp. 2018-31, DOI:10.1016/s0140-6736(10)61029-x, PMID 21131035.
(EN) Graham R. Serjeant, One hundred years of sickle cell disease, in British Journal of Haematology, vol. 151, n. 5, dicembre 2010, pp. 425-9, DOI:10.1111/j.1365-2141.2010.08419.x, PMID 20955412.
(EN) Irene Roberts e Mariane de Montalembert, Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe, in Haematologica, vol. 92, n. 7, luglio 2007, pp. 865-71, DOI:10.3324/haematol.11474, PMID 17606434.
(EN) Oniyangi O, Omari AA, Malaria chemoprophylaxis in sickle cell disease, in Oluseyi Oniyangi (a cura di), Cochrane Database of Systematic Reviews, vol. 13, n. 4, 2006, pp. CD003489, DOI:10.1002/14651858.CD003489.pub2, PMID 17054173.
(EN) Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia, in The New England Journal of Medicine, vol. 332, n. 20, 18 maggio 1995, pp. 1317-22, DOI:10.1056/NEJM199505183322001, ISSN 0028-4793 (WC · ACNP), PMID 7715639.
(EN) Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M, Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment, in JAMA, vol. 289, n. 13, 2 aprile 2003, pp. 1645-51, DOI:10.1001/jama.289.13.1645, PMID 12672732.
(EN) Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J, Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members., in JAMA, vol. 312, n. 10, 10 settembre 2014, pp. 1033-48, DOI:10.1001/jama.2014.10517, PMID 25203083.
(EN) Orah S. Platt, Hydroxyurea for the treatment of sickle cell anemia, in The New England Journal of Medicine, vol. 358, n. 13, 27 marzo 2008, pp. 1362-9, DOI:10.1056/NEJMct0708272, PMID 18367739.
(EN) Drasar E, Igbineweka N, Vasavda N, Free M, Awogbade M, Allman M, Mijovic A, Thein SL, Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years, in British Journal of Haematology, vol. 152, n. 6, marzo 2011, pp. 766-70, DOI:10.1111/j.1365-2141.2010.08451.x, PMID 21275951.
(EN) Gyang E, Yeom K, Hoppe C, Partap S, Jeng M, Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease, in American Journal of Hematology, vol. 86, n. 1, gennaio 2011, pp. 104-6, DOI:10.1002/ajh.21901, PMID 21117059.
(EN) Mirre E, Brousse V, Berteloot L, Lambot-Juhan K, Verlhac S, Boulat C, Dumont MD, Lenoir G, de Montalembert M, Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease, in European Journal of Haematology, vol. 84, n. 3, marzo 2010, pp. 259-65, DOI:10.1111/j.1600-0609.2009.01379.x, PMID 19912310.
(EN) Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC, Davies SC, Ohene-Frempong K, Bernaudin F, Matthews DC, Storb R, Sullivan KM, Bone marrow transplantation for sickle cell disease, in The New England Journal of Medicine, vol. 335, n. 6, 8 agosto 1996, pp. 369-76, DOI:10.1056/NEJM199608083350601, PMID 8663884.

unibo.it

acnpsearch.unibo.it

(EN) Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia, in The New England Journal of Medicine, vol. 332, n. 20, 18 maggio 1995, pp. 1317-22, DOI:10.1056/NEJM199505183322001, ISSN 0028-4793 (WC · ACNP), PMID 7715639.

who.int

(EN) Sickle-cell disease and other haemoglobin disorders Fact sheet N°308, su who.int, gennaio 2011. URL consultato l'8 marzo 2016.

worldcat.org

(EN) Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia, in The New England Journal of Medicine, vol. 332, n. 20, 18 maggio 1995, pp. 1317-22, DOI:10.1056/NEJM199505183322001, ISSN 0028-4793 (WC · ACNP), PMID 7715639.